Wedbush Securities’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,349
Closed -$278K – 1348
2026
Q2
$278K Buy
4,349
+632
+17% +$41.5K 0.01% 1007
2026
Q1
$265K Sell
3,717
-541
-13% -$42.7K 0.01% 967
2025
Q4
$349K Buy
4,258
+324
+8% +$25.2K 0.01% 820
2025
Q3
$295K Sell
3,934
-694
-15% -$51.8K 0.01% 867
2025
Q2
$343K Buy
4,628
+262
+6% +$18.2K 0.01% 778
2025
Q1
$352K Sell
4,366
-1,012
-19% -$87K 0.01% 744
2024
Q4
$420K Sell
5,378
-784
-13% -$66.6K 0.02% 671
2024
Q3
$578K Sell
6,162
-1,844
-23% -$155K 0.02% 553
2024
Q2
$624K Sell
8,006
-1,755
-18% -$143K 0.02% 544
2024
Q1
$887K Buy
9,761
+1,852
+23% +$154K 0.03% 427
2023
Q4
$612K Sell
7,909
-847
-10% -$59.3K 0.03% 489
2023
Q3
$596K Sell
8,756
-1,940
-18% -$141K 0.03% 458
2023
Q2
$869K Buy
10,696
+2,118
+25% +$169K 0.04% 352
2023
Q1
$704K Buy
+8,578
New +$612K 0.04% 422

Other funds holding GEHC

Wedbush Securities's GEHC Position: Q3 2026 in Review

Wedbush Securities sold out of GE HealthCare (GEHC) in Q3 2026, closing a stake of 4,349 shares — an estimated $278K sold.

Wedbush Securities first reported a position in GEHC in Q1 2023 and held it in 14 quarters. The position peaked at $887K in Q1 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Wedbush Securities reported no remaining GE HealthCare position as of Q3 2026 after selling out during the quarter.
  • Wedbush Securities sold 4,349 GE HealthCare shares in Q3 2026, an estimated $278K.
  • Wedbush Securities first reported a position in GE HealthCare in Q1 2023 and held it in 14 quarters.
  • Wedbush Securities's GE HealthCare position peaked at $887K in Q1 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Wedbush Securities's 13F filing for Q3 2026, filed 22 Oct 2026.